  The virus SARS-COV-2 caused disease COVID-19 has been declared a pandemic by
WHO. Currently, over 210 countries and territories have been affected. Careful,
well-designed drugs and vaccine for the total elimination of this virus seem to
be the need of the hour. In this context, the invivo mathematical modelling
studies can be extremely helpful in understanding the efficacy of the drug
interventions. These studies can also help understand the role of the crucial
inflammatory mediators and the behaviour of immune response towards this novel
coronavirus. Motivated by these facts, in this paper, we study the invivo
dynamics of Covid-19. The results obtained here are inline with some of the
clinical findings for Covid-19. This invivo modelling study involving the
crucial biomarkers of Covid-19 is the first of its kind and the results
obtained from this can be helpful to researchers, epidemiologists, clinicians
and doctors who are working in this field.
